Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mai D. Sirimanne
Observed name:
Mai Sirimanne
Institution:
Allergan (United States)
Observed institution:
Allergan (United States)
OpenAlex ID:
A5035476342
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
2013
·
Stephen D. Silberstein
, Andrew M. Blumenfeld
, et al.
·
Journal of the Neurological Sciences
·
228
A Randomized Phase 1 Safety Study of Repeated Doses of Intranasal OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adults: A Potential Treatment for Otitis Media
2020
·
Mai D. Sirimanne
, Janak A. Patel
, et al.
PDF
Show more works
View as search
Works count:
2
Citation count:
228
H-index:
1
I10-index:
1
Year
Topic
Type